Pharmacokinetics of Recombinant Human Tumor Necrosis Factor Alpha in the Delivery System
The main problems of using TNF-alpha in antitumor therapy are its rapid degradation in the bloodstream and the limited selectivity of accumulation in the tumor tissue. The SRC VB «Vector» developed a biodegradable molecular construct that provides protection against proteases and ensures targeted de...
Main Authors: | A. V. Bateneva, O. V. Simakova, S. G. Gamaley, E. A. Volosnikova, L. R. Lebedev, E. D. Danilenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2019-09-01
|
Series: | Биопрепараты: Профилактика, диагностика, лечение |
Subjects: | |
Online Access: | https://www.biopreparations.ru/jour/article/view/232 |
Similar Items
-
EFFECT OF CISPLATIN ON HEMOSTASIS IN EXPERIMENTAL ANIMALS
by: M. V. Filonova, et al.
Published: (2020-07-01) -
Genomic, microbial and environmental standardization in animal experimentation limiting immunological discovery
by: Josue Enriquez, et al.
Published: (2020-09-01) -
In vitro and in vivo activities of Peganum harmala extract against Leishmania major
by: Parvaneh Rahimi-Moghaddam, et al.
Published: (2011-01-01) -
MEDICINAL FORM OF TNF-α FOR LOCAL ADMINISTRATION
by: S. G. Gamaley, et al.
Published: (2012-05-01) -
DEVELOPMENT OF OPTIMAL EXPERIMENTAL THERAPEUTIC REGIMENS ADMINISTRATION OF IMMOBILIZED INTERFERON α-2b
by: O. G. Shitikova, et al.
Published: (2014-10-01)